Page last updated: 2024-08-22

hyaluronoglucosaminidase and Angioedema, Hereditary, Type I

hyaluronoglucosaminidase has been researched along with Angioedema, Hereditary, Type I in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fridman, M; Magerl, M; Maurer, M; Schranz, J; Supina, D; Weller, K	1

Trials

1 trial(s) available for hyaluronoglucosaminidase and Angioedema, Hereditary, Type I

Article	Year
Health-related quality of life with hereditary angioedema following prophylaxis with subcutaneous C1-inhibitor with recombinant hyaluronidase. Allergy and asthma proceedings, 2017, Mar-16, Volume: 38, Issue:2 Topics: Administration, Intravenous; Adult; Complement C1 Inhibitor Protein; Complement Inactivating Agents; Cross-Over Studies; Double-Blind Method; Female; Health Status; Hereditary Angioedema Types I and II; Humans; Hyaluronoglucosaminidase; Infusions, Subcutaneous; Male; Middle Aged; Quality of Life; Recombinant Proteins; Secondary Prevention; Surveys and Questionnaires; Treatment Outcome	2017

Article

Year

Allergy and asthma proceedings, 2017, Mar-16, Volume: 38, Issue:2

Topics: Administration, Intravenous; Adult; Complement C1 Inhibitor Protein; Complement Inactivating Agents; Cross-Over Studies; Double-Blind Method; Female; Health Status; Hereditary Angioedema Types I and II; Humans; Hyaluronoglucosaminidase; Infusions, Subcutaneous; Male; Middle Aged; Quality of Life; Recombinant Proteins; Secondary Prevention; Surveys and Questionnaires; Treatment Outcome

2017